J. Wu

First name
J.
Last name
Wu
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Arbel, R., Haim, M., et al. (2024). Risk calculator for incident atrial fibrillation across a range of prediction horizons. Am Heart J, 272, 1-10. http://doi.org/10.1016/j.ahj.2024.03.001
View
Nakao, Y. M., Nadarajah, R., Shuweihdi, F., Nakao, K., Fuat, A., Moore, J., et al. (2024). Predicting incident heart failure from population-based nationwide electronic health records: protocol for a model development and validation study. Bmj Open, 14, e073455. http://doi.org/10.1136/bmjopen-2023-073455
View
Nadarajah, R., Wu, J., Arbel, R., Haim, M., Zahger, D., Benita, T. R., et al. (2023). Risk of atrial fibrillation and association with other diseases: protocol of the derivation and international external validation of a prediction model using nationwide population-based electronic health records. Bmj Open, 13, e075196. http://doi.org/10.1136/bmjopen-2023-075196
View
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Wilkinson, C., Cowan, J. C., et al. (2023). Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation. Eur Heart J. http://doi.org/10.1093/eurheartj/ehad571
View
Nakao, Y. M., Nakao, K., Nadarajah, R., Banerjee, A., Fonarow, G. C., Petrie, M. C., et al. (2023). Prognosis, characteristics, and provision of care for patients with the unspecified heart failure electronic health record phenotype: a population-based linked cohort study of 95262 individuals. Eclinicalmedicine, 63, 102164. http://doi.org/10.1016/j.eclinm.2023.102164
View
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Hogg, D., Raveendra, K., et al. (2023). Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study. Open Heart, 10. http://doi.org/10.1136/openhrt-2023-002357
View
Nadarajah, R., Wu, J., Hogg, D., Raveendra, K., Nakao, Y. M., Nakao, K., et al. (2023). Prediction of short-term atrial fibrillation risk using primary care electronic health records. Heart. http://doi.org/10.1136/heartjnl-2022-322076
View
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Wilkinson, C., Mamas, M. A., et al. (2022). Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals. Lancet Reg Health Eur, 17, 100386. http://doi.org/10.1016/j.lanepe.2022.100386
View
Wu, J., Mackie, S. L., & Pujades-Rodriguez, M. (2020). Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2020-001220
View
Pujades-Rodriguez, M., Morgan, A. W., Cubbon, R. M., & Wu, J. (2020). Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoS Med. http://doi.org/10.1371/journal.pmed.1003432
View